Skip to main content
Log in

Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet's disease

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The objective of this study was to measure soluble intercellular adhesion molecule-1 (sICAM-1) in patients with Behçet's disease (BD) and to analyse the relationship of sICAM-1 levels with clinical and some laboratory measures of disease activity. Forty patients with BD fulfilling the International Study Group Criteria for the diagnosis of BD and 20 healthy controls were studied. Twenty patients had active, and 20 patients had inactive disease. Serum sICAM-1 was determined by a sandwich ELISA. The mean (±SD) sICAM-1 level was significantly higher in the whole BD group (297.3±86.6 ng/ml) than in the healthy controls (213±83.5 ng/ml; P< 0.05). The mean sICAM-1 levels in active and inactive BD patients were 315.7±76.3 ng/ml and 258.3±73.3 ng/ml, respectively. The mean sICAM-1 level in active patients was significantly higher than in inactive patients and healthy controls (P< 0.02 and P< 0.001, respectively). No statistically significant difference in mean sICAM-1 levels was found between inactive BD patients and healthy controls (P>0.05). There was no statistically significant difference between the mean sICAM-1 levels of active patients with (351.3±77.2 ng/ml) or without vascular lesions (292±68.8; P>0.05). In spite of a positive correlation between disease activity and both erythrocyte sedimentation rate and C-reactive protein (CRP; P< 0.01), we found no correlation between sICAM-1 and either of them (P>0.05). The elevated levels of sICAM-1 may be due to endothelial cell activation and/or damage or may be the result of inflammation. In either case it did not seem to be superior to more conventional measures of disease activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rothlein R, Dustin ML, Marlin SD, Springer TA (1986) A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 137:1270–1274

    Google Scholar 

  2. Marlin SD, Springer SA (1987) Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 51:813–819

    Google Scholar 

  3. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA (1988) Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52:925–933

    Google Scholar 

  4. Springer T (1900) Adhesion receptors of the immune system. Nature 346:425–434

    Google Scholar 

  5. Smith ME, Thomas JA (1990) Cellular expression of lymphocyte function associated antigens and the intercellular adhesion molecule-1 in normal tissue. J Clin Pathol 43:893–900

    Google Scholar 

  6. Rothlein R, Czajkowski M, O'Neill MM, Marlin SD, Mainolfi E, Merluzzi VJ (1988) Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by proinflammatory cytokines: regulation by pharmacologic agents and neutralizing antibodies. J Immunol 141:1665–1669

    Google Scholar 

  7. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA (1986) Induction by IL-1 and interferon gamma: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J Immunol 137:245–254

    Google Scholar 

  8. Pober JS, Lapierre LA, Stolpen AH, Brock TA, Springer TA, Fiers W, Bevilacqua MP, Mendrick DL, Gimbrone MA (1987) Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J Immunol 138:3319–3324

    Google Scholar 

  9. Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DC (1989) Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 83:2008–2017

    Google Scholar 

  10. Dougherty GJ, Murdoch S, Hogg N (1988) The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an immune response. Eur J Immunol 18:35–39

    Google Scholar 

  11. Seth R, Raymond FD, Makgoba MW (1991) Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 338:83–84

    Google Scholar 

  12. Ballantyne C, Mainolfi EA, Young JB, Windsor NT, Cocanougher B, Lawrence EC, Anderson DC, Rothlein R (1991) Prognostic value of increased levels of circulating intercellular adhesion molecule-1 after heart transplant. Clin Res 39:285 a

    Google Scholar 

  13. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD (1991) A form of circulating ICAM-1 in human serum. J Immunol 147:3788–3793

    Google Scholar 

  14. Adams DH, Mainolfi E, Burra P, Neuberger JM, Ayres R, Elias E, Rothlein R (1992) Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology 16:810–814

    Google Scholar 

  15. Furukawa S, Imai K, Matsubara T, Yone K, Yachi A, Okumura K, Yabuta K (1992) Increased levels of circulating intercellular adhesion molecule-1 in Kawasaki disease. Arthritis Rheum 35:672–677

    Google Scholar 

  16. Shijubo N, Imai K, Aoki S, Hirasawa M, Sugawara H, Koba H, Tsujisaki M, Sugiyama T, Hinoda Y, Yachi A, Asakawa M, Suzuki A (1992) Circulating intercellular adhesion molecule-1 antigen in sera of patients with idiopathic pulmonary fibrosis. Clin Exp Immunol 89:58–62

    Google Scholar 

  17. Cush JJ, Rothlein R, Lindsley HB, Mainolfi EA, Lipsky PE (1993) Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis. Arthritis Rheum 36:1098–1102

    Google Scholar 

  18. Mason JC, Kapahi P, Haskard DO (1993) Detection of increased levels of circulating intercellular adhesion molecule in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Arthritis Rheum 4:519–527

    Google Scholar 

  19. Sfikakis PP, Tesar J, Baraf H, Lipnick R, Klipple G, Tsokos GC (1993) Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis. Clin Immunol Immunopathol 68:88–92

    Google Scholar 

  20. Hauschild S, Schmitt WH, Kekow J, Szymkowiak C, Gross WL (1992) Elevated serum levels of ICAM-1 in Wegener's granulomatosis. Immun Infect 20:84–85

    Google Scholar 

  21. Machold KP, Kiener HP, Graninger W, Graninger WB (1993) Soluble intercellular adhesion molecule-1 in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol 68:74–78

    Google Scholar 

  22. Mizushima Y (1986) Chemotaxis and phagocytosis of leucocytes in Behçet's disease: an overview. In: Lehner T, Barnes CG (eds) Recent advances in Behçet's disease. Royal Society of Medicine Services, London, pp 85–86

    Google Scholar 

  23. Jorizzo JL, Solomon AR, Cavalho T (1985) Behçet's syndrome, immunopathologic and histologic assessment of pathergy lesions is useful in diagnosis and follow-up. Arch Pathol Lab Med 109:745–751

    Google Scholar 

  24. Chun S, Su DWP, Lee S (1990) Histopathologic study of cutaneous lesions in Behçet's syndrome. J Dermatol 17:333–341

    Google Scholar 

  25. International Study Group for Behçet's Disease (1990) Criteria for the diagnosis of Behçet's disease. Lancet 335:1078–1080

    Google Scholar 

  26. Aydintuĝ AO, Tokgöz G, Jedryka-Goral A, D'Cruz D, Gürler A, Khamashta MA, Hughes GRV (1993) Von Willebrand factor antigen in patients with Behçet's disease. In: Wechsler B, Godeau P (eds) Behçet's disease (International congress series). Elsevier, Amsterdam, pp 131–133

    Google Scholar 

  27. Aydintuĝ AO, Tokgöz G, D'Cruz DP, Gürler A, Cervera R, Düzgün N, Atmaca LS, Khamashta MA, Hughes GRV (1993) Antibodies to endothelial cells in patients with Behçet's disease. Clin Immunol Immunopathol 67:157–162

    Google Scholar 

  28. Hamzaoui K, Ayed K, Slim A, Hamza M, Touraine J (1990) Natural killer cell activity, interferon gamma and antibodies to herpes viruses in patients with Behçet's disease. Clin Exp Immunol 79:28–34

    Google Scholar 

  29. Hamzaoui K, Hamza M, Ayed K (1990) Production of TNF-alpha and IL-1 in active Behçet's disease. J Rheumatol 17:1428–1429

    Google Scholar 

  30. Mege J, Dilşen N, Sanguedolce V, Gül A, Bongrand P, Roux H, Öcal L, Inanç M, Capo C (1993) Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial mediterranean fever and healthy subjects. J Rheumatol 20:1544–1549

    Google Scholar 

  31. Gül A, Esin S, Dilşen N, Wigzell H, Biberfeld P (1993) Immunohistology of skin pathergy reaction in Behçet's disease. In: Wechsler B, Godeau P (eds) Behçet's disease. (International congress series). Elsevier, Amsterdam, pp 343–347

    Google Scholar 

  32. Aoki S, Imai K, Yachi A (1993) Soluble intercellular adhesion molecule-1 (ICAM-1) antigen in patients with rheumatoid arthritis. Scand J Immunol 38:485–490

    Google Scholar 

  33. Cronstein BN, Weissmann G (1993) The adhesion molecules of inflammation. Arthritis Rheum 36:147–157

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aydintuĝ, A.O., Tokgöz, G., Özoran, K. et al. Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet's disease. Rheumatol Int 15, 75–78 (1995). https://doi.org/10.1007/BF00262712

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00262712

Key words

Navigation